Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia

Vaccine

Volumn 29, Issue 36, 2011, Pages 6125-6129

  Gray, Richard T ^a   Ghaus, Mohammad H ^a   Hoare, Alexander ^a   Wilson, David P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; HIV vaccine; Individual based; Mathematical model; MSM

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; AUSTRALIA; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MATHEMATICAL MODEL; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VACCINATION;

AIDS VACCINES; CIRCUMCISION, MALE; HIV; HIV INFECTIONS; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INCIDENCE; MALE; MODELS, THEORETICAL; NEW SOUTH WALES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEXUAL BEHAVIOR; SEXUAL PARTNERS; VACCINATION;

EID: 80051474269     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.061     Document Type: Article

References (22)

1. Letvin N.L. Progress and obstacles in the development of an AIDS vaccine. Nature reviews. Immunology 2006, 6:930-939.
2. Johnston M., Fauci A. An HIV vaccine-challenges and prospects. The New England Journal of Medicine 2008, 359:888-890.
3. Girard M.P., Osmanov S.K., Kieny M.P. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 2006, 24:4062-4081.
4. Buchbinder S., Mehrotra D., Duerr A., Fitzgerald D., Mogg R., Li D., et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. The Lancet 2008, 372:1881-1893.
5. Cohen J. Did Merck's failed HIV vaccine cause harm?. Science 2007, 318:1048-1049.
6. Rerks-Ngram S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. The New England Journal of Medicine 2009, 361:2209-2220.
7. Butler D. Jury still out on HIV vaccine results. Nature 2009, 461:2009-12009.
8. Research, N.C.I.H.E.A.C. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010, in Public Health; 2010.
9. UNAIDS. UNAIDS Report on the Global AIDS Epidemic 2010; 2010.
10. Amirfar S., Hollenberg J.P., Abdool Karim S.S. Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa. Journal of Acquired Immune Deficiency Syndromes 2006, 43:219-225.
11. Blower S.M., Koelle K., Kirschner D.E., Mills J., et al. Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(6):3618-3623.
12. Bogard E., Kuntz K.M. The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model. Journal of Acquired Immune Deficiency Syndromes 2002, 29:132-141.
13. Wilson DP, Prestage GP, Gray RT, Ghaus MH, Hoare A, Down I, et al. HIV in New South Wales: modelling evidence and research on acceptability of public health interventions 2010. Sydney; 2010.
14. Jin F. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS (London, England) 2009, 23:243-252.
15. Mao L., Crawford J.M., Hospers J.H., Prestage G.P., Grulich A.E., Kaldor J.M., et al. 'Serosorting' in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS (London, England) 2006, 20:1204-1206.
16. Wilson D.P., Regan D.G., Heymer K.-J., Jin F., Prestage G.P., Grulich A.E. Serosorting may increase the risk of HIV acquisition among men who have sex with men. Sexually Transmitted Diseases 2010, 37:13-17.
17. Prestag G.P., Ferris J., Grierson J., Thorpe R., Zablotska I., Imrie J., et al. Homosexual men in Australia: population, distributionand HIV prevalence. Sexual Health 2008, 5:97-102.
18. Grant R.M., Lama J.R., Anderson P.L., McMahan V., Liu A.Y., Vargas L., et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. The New England Journal of Medicine 2010, 363:2587-2599.
19. Kaldor J.M., Wilson D.P. How low can you go: the impact of a modestly effective HIV vaccine compared with male circumcision. AIDS (London, England) 2010, 24:2573-2578.
20. Anderson J., Wilson D., Templeton D.J., Grulich A.E., Carte R., Kaldor J.M., et al. Cost-effectiveness of adult circumcision in a resource-rich setting for HIV prevention among men who have sex with men. The Journal of Infectious Diseases 2009, 200:1803-1812.
21. Londish G.J., Templeton D.J., Regan D.G., Kaldor J.M., Murray J.M., et al. Minimal impact of circumcision on HIV acquisition in men who have sex with men. Sexual Health 2010, 7:463-470.
22. Templeton D.J., Jin F., Mao L., Prestage G.P., Donovan B., Imrie J., et al. Circumcision and risk of HIV infection in Australian homosexual men. AIDS (London, England) 2009, 23:2347-2351.